Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2000-07-11
2002-10-08
Reamer, James H. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S034000, C514S183000, C514S212010, C514S237800, C514S255030, C514S275000, C514S303000, C514S311000, C514S313000, C514S316000, C514S331000, C514S400000, C514S415000, C514S427000, C514S455000
Reexamination Certificate
active
06462024
ABSTRACT:
The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart.
The present invention relates to the use of inhibitors of the sodium-hydrogen exchanger for decreasing functional impairment of the heart in human and veterinary medicine, such as can be caused, for example, by animal and plant cardiotoxins, by pharmaceuticals having a cardiotoxic component or by pharmaceuticals having undesired side effects on the heart and can cause health disorders due to chronic or acute absorption into the body.
REFERENCES:
patent: 5292755 (1994-03-01), Englert et al.
patent: 5364868 (1994-11-01), Englert et al.
Heitsch Holger
Lang Hans Jochen
Linz Wolfgang
Rütten Hartmut
Schölkens Bernward
Aventis Pharma Deutschland GmbH
Finnegan Henderson Farabow Garrett & Dunner LLP
Reamer James H.
LandOfFree
Use of inhibitors of the sodium-hydrogen exchanger for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inhibitors of the sodium-hydrogen exchanger for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of the sodium-hydrogen exchanger for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2978101